Will be interesting to see if IMU gets more of a bump during and after its conference today. MASSIVE buy side demand with 220 buyers for 107,568,372 units vs 61 sellers for 26,085,482 units.
Imugene Limited is an immuno-oncology focused biopharmaceutical company. The Company is engaged in the research and development of human epidermal growth factor receptor 2...
Love this stock fundamentally but in my opinion, it has had a great short-term run and needs a pullback for the next leg up. Should see it retrace to these support levels and then continue upwards towards 5c short term. I will be selling a portion to rebuy at a lower price.
